Bordoni et al. compared treated and untreated patients, revealing higher infection rates of CD34+ HSPCs in treatment-naïve patients (cART+ 7 copies/1000 cells; cART−: 72 copies/1000 cells) [92]. This evidence concerns the gene CD34 and infection.